Cargando…

Determinants of health-related quality of life decline in interstitial lung disease

BACKGROUND: Health-related quality of life (HRQL) in interstitial lung disease (ILD) patients is impaired. We aimed to identify baseline predictors for HRQL decline within a 12-month observation period. METHODS: We analyzed 194 ILD patients from two German ILD-centers in the observational HILDA stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Maqhuzu, Phillen Nozibuyiso, Szentes, Boglarka L., Kreuter, Michael, Bahmer, Thomas, Kahn, Nicolas, Claussen, Martin, Holle, Rolf, Schwarzkopf, Larissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542726/
https://www.ncbi.nlm.nih.gov/pubmed/33032602
http://dx.doi.org/10.1186/s12955-020-01570-2
_version_ 1783591601126244352
author Maqhuzu, Phillen Nozibuyiso
Szentes, Boglarka L.
Kreuter, Michael
Bahmer, Thomas
Kahn, Nicolas
Claussen, Martin
Holle, Rolf
Schwarzkopf, Larissa
author_facet Maqhuzu, Phillen Nozibuyiso
Szentes, Boglarka L.
Kreuter, Michael
Bahmer, Thomas
Kahn, Nicolas
Claussen, Martin
Holle, Rolf
Schwarzkopf, Larissa
author_sort Maqhuzu, Phillen Nozibuyiso
collection PubMed
description BACKGROUND: Health-related quality of life (HRQL) in interstitial lung disease (ILD) patients is impaired. We aimed to identify baseline predictors for HRQL decline within a 12-month observation period. METHODS: We analyzed 194 ILD patients from two German ILD-centers in the observational HILDA study. We employed the disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) with the subdomains ‘psychological impact’, ‘chest symptoms’ and ‘breathlessness and activities’, and the generic EQ-5D Visual Analog Scale (VAS). We evaluated how many patients experienced a clinically meaningful decline in HRQL. Subsequently, we investigated medical and sociodemographic factors as potential predictors of HRQL deterioration. RESULTS: Within the study population (34.0% male, Ø age 61.7) mean HRQL scores hardly changed between baseline and follow up (K-BILD: 52.8 vs. 52.5 | VAS: 60.0 vs. 57.3). On the intra-individual level, 30.4% (n = 59) experienced a clinically relevant deterioration in K-BILD total score and 35.4% (n = 68) in VAS. Lower baseline forced vital capacity (FVC) % predicted determined HRQL decline in K-BILD total score (ß-coefficient: − 0.02, p = 0.007), VAS (ß-coefficient: − 0.03, p < 0.0001), and in the subdomain ‘psychological impact’ (ß-coefficient: − 0.02, p = 0.014). Lower baseline diffusing capacity of carbon monoxide (DLCO) % predicted determined deterioration in ‘breathlessness and activities’ (ß-coefficient: − 0.04, p = 0.003) and ‘chest symptoms’ (ß-coefficient: − 0.04, p = 0.002). Additionally, increasing age predicted decline in ‘psychological impact’ (ß-coefficient: 0.06, p < 0.007). CONCLUSION: Around a third of ILD patients experienced a clinically relevant HRQL deterioration in a 12-month period, which was associated with baseline lung function values in all K-BILD domains. As lung function values are time-dependent variables with possible improvements, in contrast to age and ILD subtype, it, thus, seems important to improve lung function and prevent its decline in order to maintain HRQL on the possibly highest level.
format Online
Article
Text
id pubmed-7542726
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75427262020-10-08 Determinants of health-related quality of life decline in interstitial lung disease Maqhuzu, Phillen Nozibuyiso Szentes, Boglarka L. Kreuter, Michael Bahmer, Thomas Kahn, Nicolas Claussen, Martin Holle, Rolf Schwarzkopf, Larissa Health Qual Life Outcomes Research BACKGROUND: Health-related quality of life (HRQL) in interstitial lung disease (ILD) patients is impaired. We aimed to identify baseline predictors for HRQL decline within a 12-month observation period. METHODS: We analyzed 194 ILD patients from two German ILD-centers in the observational HILDA study. We employed the disease-specific King’s Brief Interstitial Lung Disease questionnaire (K-BILD) with the subdomains ‘psychological impact’, ‘chest symptoms’ and ‘breathlessness and activities’, and the generic EQ-5D Visual Analog Scale (VAS). We evaluated how many patients experienced a clinically meaningful decline in HRQL. Subsequently, we investigated medical and sociodemographic factors as potential predictors of HRQL deterioration. RESULTS: Within the study population (34.0% male, Ø age 61.7) mean HRQL scores hardly changed between baseline and follow up (K-BILD: 52.8 vs. 52.5 | VAS: 60.0 vs. 57.3). On the intra-individual level, 30.4% (n = 59) experienced a clinically relevant deterioration in K-BILD total score and 35.4% (n = 68) in VAS. Lower baseline forced vital capacity (FVC) % predicted determined HRQL decline in K-BILD total score (ß-coefficient: − 0.02, p = 0.007), VAS (ß-coefficient: − 0.03, p < 0.0001), and in the subdomain ‘psychological impact’ (ß-coefficient: − 0.02, p = 0.014). Lower baseline diffusing capacity of carbon monoxide (DLCO) % predicted determined deterioration in ‘breathlessness and activities’ (ß-coefficient: − 0.04, p = 0.003) and ‘chest symptoms’ (ß-coefficient: − 0.04, p = 0.002). Additionally, increasing age predicted decline in ‘psychological impact’ (ß-coefficient: 0.06, p < 0.007). CONCLUSION: Around a third of ILD patients experienced a clinically relevant HRQL deterioration in a 12-month period, which was associated with baseline lung function values in all K-BILD domains. As lung function values are time-dependent variables with possible improvements, in contrast to age and ILD subtype, it, thus, seems important to improve lung function and prevent its decline in order to maintain HRQL on the possibly highest level. BioMed Central 2020-10-08 /pmc/articles/PMC7542726/ /pubmed/33032602 http://dx.doi.org/10.1186/s12955-020-01570-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Maqhuzu, Phillen Nozibuyiso
Szentes, Boglarka L.
Kreuter, Michael
Bahmer, Thomas
Kahn, Nicolas
Claussen, Martin
Holle, Rolf
Schwarzkopf, Larissa
Determinants of health-related quality of life decline in interstitial lung disease
title Determinants of health-related quality of life decline in interstitial lung disease
title_full Determinants of health-related quality of life decline in interstitial lung disease
title_fullStr Determinants of health-related quality of life decline in interstitial lung disease
title_full_unstemmed Determinants of health-related quality of life decline in interstitial lung disease
title_short Determinants of health-related quality of life decline in interstitial lung disease
title_sort determinants of health-related quality of life decline in interstitial lung disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542726/
https://www.ncbi.nlm.nih.gov/pubmed/33032602
http://dx.doi.org/10.1186/s12955-020-01570-2
work_keys_str_mv AT maqhuzuphillennozibuyiso determinantsofhealthrelatedqualityoflifedeclineininterstitiallungdisease
AT szentesboglarkal determinantsofhealthrelatedqualityoflifedeclineininterstitiallungdisease
AT kreutermichael determinantsofhealthrelatedqualityoflifedeclineininterstitiallungdisease
AT bahmerthomas determinantsofhealthrelatedqualityoflifedeclineininterstitiallungdisease
AT kahnnicolas determinantsofhealthrelatedqualityoflifedeclineininterstitiallungdisease
AT claussenmartin determinantsofhealthrelatedqualityoflifedeclineininterstitiallungdisease
AT hollerolf determinantsofhealthrelatedqualityoflifedeclineininterstitiallungdisease
AT schwarzkopflarissa determinantsofhealthrelatedqualityoflifedeclineininterstitiallungdisease